Invention Grant
- Patent Title: Antibodies specific to glycoprotein (GP) of Ebolavirus and uses for the treatment and diagnosis of ebola virus infection
-
Application No.: US15548883Application Date: 2016-02-08
-
Publication No.: US10266584B2Publication Date: 2019-04-23
- Inventor: Olivier Reynard , Viktor Volchkov
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITÉ CLAUDE BERNARD—LYON 1 , ENS—ECOLE NORMALE SUPÉRIEURE DE LYON , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Applicant Address: FR Paris FR Villeurbanne FR Lyons FR Paris
- Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),Université Claude Bernard—Lyon 1,ENS—Ecole Normale Superieure de Lyon,Centre National de la Recherche Scientifique (CNRS)
- Current Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),Université Claude Bernard—Lyon 1,ENS—Ecole Normale Superieure de Lyon,Centre National de la Recherche Scientifique (CNRS)
- Current Assignee Address: FR Paris FR Villeurbanne FR Lyons FR Paris
- Agency: W & C IP
- Priority: EP15305191 20150210; EP15305348 20150306
- International Application: PCT/EP2016/052614 WO 20160208
- International Announcement: WO2016/128349 WO 20160818
- Main IPC: C07K16/10
- IPC: C07K16/10 ; G01N33/569
Abstract:
The present invention relates to antibodies or fragments thereof that specifically bind to glycoprotein (GP) of Ebola virus, and to their use for treating and diagnosing Ebola virus disease.
Public/Granted literature
Information query
